findmyKOL
Clinical trialNCT05571059RecruitingPhase 2Interventional

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

SponsorCumberland PharmaceuticalsEnrollment128Idiopathic Pulmonary Fibrosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Biosolutions Clinical Research

    La Mesa, California, United States

    Kaveh Bagheri, MD
    Recruiting
  • University of California San Francisco

    San Francisco, California, United States

    Jeffrey Golden, MD
    Recruiting
  • Mayo Clinic Jacksonville

    Jacksonville, Florida, United States

    Augustine Lee, MD
    Recruiting
  • Miami Va Health System

    Miami, Florida, United States

    Robert Jackson, MD
    Recruiting
  • Northwestern Medicine

    Chicago, Illinois, United States

    Krishnan Warrior, MD
    Recruiting
  • Indiana University Health

    Indianapolis, Indiana, United States

    Damien Patel, MD
    Recruiting
  • University of Kansas

    Kansas City, Kansas, United States

    Mark Hamblin, MD
    Recruiting
  • University of Louisville

    Louisville, Kentucky, United States

    Mohamed Saad, MD
    Recruiting
  • Beaumont Hospital, Royal Oak

    Royal Oak, Michigan, United States

    Enrique Calvo-Ayala, MD
    Recruiting
  • Icahn School of Medicine at Mount Sinai

    New York, New York, United States

    Maria Padilla, MD
    Recruiting
  • University of Rochester

    Rochester, New York, United States

    David Nagel, MD, PhD
    Recruiting
  • Unc Chapel Hill

    Chapel Hill, North Carolina, United States

    Recruiting
  • Bend Memorial Hospital

    Bend, Oregon, United States

    Jeremy Feldman, MD
    Recruiting
  • Temple University Hospital

    Philadelphia, Pennsylvania, United States

    Gerard Criner, MD
    Recruiting
  • Avera Research Institute

    Sioux Falls, South Dakota, United States

    Fady Jamous, MD
    Recruiting
  • Pulmonary & Sleep Specialists

    Dickson, Tennessee, United States

    Mohammad Alsoub, MD
    Recruiting
  • Baylor University Medical Center

    Dallas, Texas, United States

    Susan Mathai, MD
    Recruiting
  • Premier Pulmonary Critical Care and Sleep Medicine

    Denison, Texas, United States

    Sanober Kable, MD
    Recruiting
  • Uw Health University Hospital

    Madison, Wisconsin, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2024
Primary completion
31 Jan 2027
Completion
31 Jan 2027
Last update posted
5 Mar 2026
Registered enrollment
128
Registry id
NCT05571059

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.